The White House is contemplating a bold move that could revolutionize the marijuana landscape: reclassifying the drug to reduce restrictions. This decision, if executed, would be a game-changer for many.
President Donald Trump revealed on Monday that the administration is seriously contemplating an executive order to downgrade marijuana's classification, making it a Schedule III drug. This reclassification would open doors to extensive research, a prospect that has garnered significant public interest.
Trump's statement builds upon his previous commitment to a more lenient marijuana policy, which he expressed during his 2024 presidential campaign. He envisioned a future where adults could access safe products and states could legalize marijuana with greater flexibility.
Here's where it gets intriguing: the Drug Enforcement Administration (DEA) currently categorizes marijuana as a Schedule I drug, alongside heroin, LSD, and meth, due to its perceived high potential for abuse and lack of accepted medical use. But the White House is considering a shift to Schedule III, which the DEA defines as drugs with a moderate to low potential for dependence.
And this is the part most people miss: the White House has been quietly consulting with industry groups, indicating a potential announcement on rescheduling as early as this week. However, a White House official maintained that no final decision has been made yet.
The discussions have involved key figures like Chief of Staff Susie Wiles, Health and Human Services Secretary Robert F. Kennedy Jr., and representatives from the cannabis industry, including Kim Rivers from Trulieve and Jim Hagedorn from Scotts Miracle-Gro's cannabis division.
Trump's support for marijuana policy reform is not new. He previously advocated for allowing weed companies to access banking services and for universities to conduct research on the drug. He even voted for recreational marijuana legalization in Florida.
The White House's internal debate on rescheduling marijuana comes at a critical time, as Trump's popularity among young voters is waning ahead of the 2026 midterms. This move could be a strategic attempt to appeal to this demographic, but it remains to be seen whether it will be enough to sway their votes.
The question is, will this potential reclassification be the turning point in marijuana policy that many have been waiting for?
